help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xie, W.
Right arrow Articles by Safe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xie, W.
Right arrow Articles by Safe, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Endocrinology Vol. 141, No. 7 2439-2449
Copyright © 2000 by The Endocrine Society

ARTICLES

Transcriptional Activation of Thymidylate Synthase by 17ß-Estradiol in MCF-7 Human Breast Cancer Cells1

Wen Xie, Reqin Duan, Ichen Chen, Ismael Samudio and Stephen Safe2

Department of Veterinary Physiology and Pharmacology, Texas A & M University, College Station, Texas 77843-4466

Address all correspondence and requests for reprints to: Dr. Stephen H. Safe, Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843-4466. E-mail: ssafe{at}cvm.tamu.edu

Thymidylate synthase (TS) catalyzes methylation of deoxyuridine phosphate to give deoxythymidine phosphate, and 17ß-estradiol (E2) induces TS gene expression in MCF-7 human breast cancer cells. Analysis of the TS gene promoter showed that E2-responsiveness required the -229 to -140 promoter region containing a G-rich sequence and CACCC box. Subsequent mutational analysis of this region indicated that only the G-rich motif (-150 to -142) was required for E2 action. Results of gel mobility shift and in vitro DNA footprinting assays showed that both estrogen receptor {alpha} (ER{alpha}) and Sp1 proteins were required for hormone-induced trans-activation that involved ER{alpha}/Sp1 binding to the G-rich site in which only Sp1 protein bound DNA. Both proteins also interacted in Drosophila cells in functional assays, confirming the transcriptional activation of TS-involved ER{alpha}/Sp1, and this adds to the increasing number of genes that are activated through this pathway in breast cancer cells.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
N. S. Wickramasinghe, T. T. Manavalan, S. M. Dougherty, K. A. Riggs, Y. Li, and C. M. Klinge
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
Nucleic Acids Res., May 1, 2009; 37(8): 2584 - 2595.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W.-H. Xu, J.-R. Long, W. Zheng, Z.-X. Ruan, Q. Cai, J.-R. Cheng, G.-M. Zhao, Y.-B. Xiang, and X.-O. Shu
Association of Thymidylate Synthase Gene with Endometrial Cancer Risk in a Chinese Population
Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 579 - 584.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S. Safe and K. Kim
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways
J. Mol. Endocrinol., November 1, 2008; 41(5): 263 - 275.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S. Khan, F. Wu, S. Liu, Q. Wu, and S. Safe
Role of specificity protein transcription factors in estrogen-induced gene expression in MCF-7 breast cancer cells
J. Mol. Endocrinol., October 1, 2007; 39(4): 289 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Kim, R. Barhoumi, R. Burghardt, and S. Safe
Analysis of Estrogen Receptor {alpha}-Sp1 Interactions in Breast Cancer Cells by Fluorescence Resonance Energy Transfer
Mol. Endocrinol., April 1, 2005; 19(4): 843 - 854.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
Y-L Zhao, W-D Han, Q Li, Y-M Mu, X-C Lu, L Yu, H-J Song, X Li, J-M Lu, and C-Y Pan
Mechanism of transcriptional regulation of LRP16 gene expression by 17-{beta} estradiol in MCF-7 human breast cancer cells
J. Mol. Endocrinol., February 1, 2005; 34(1): 77 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
V. X. Jin, Y.-W. Leu, S. Liyanarachchi, H. Sun, M. Fan, K. P. Nephew, T. H.-M. Huang, and R. V. Davuluri
Identifying estrogen receptor {alpha} target genes using integrated computational genomics and chromatin immunoprecipitation microarray
Nucleic Acids Res., December 17, 2004; 32(22): 6627 - 6635.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. O'Lone, M. C. Frith, E. K. Karlsson, and U. Hansen
Genomic Targets of Nuclear Estrogen Receptors
Mol. Endocrinol., August 1, 2004; 18(8): 1859 - 1875.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Khan, M. Abdelrahim, I. Samudio, and S. Safe
Estrogen Receptor/Sp1 Complexes Are Required for Induction of cad Gene Expression by 17{beta}-Estradiol in Breast Cancer Cells
Endocrinology, June 1, 2003; 144(6): 2325 - 2335.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Ngwenya and S. Safe
Cell Context-Dependent Differences in the Induction of E2F-1 Gene Expression by 17{beta}-Estradiol in MCF-7 and ZR-75 Cells
Endocrinology, May 1, 2003; 144(5): 1675 - 1685.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Kim, N. Thu, B. Saville, and S. Safe
Domains of Estrogen Receptor {alpha} (ER{alpha}) Required for ER{alpha}/Sp1-Mediated Activation of GC-Rich Promoters by Estrogens and Antiestrogens in Breast Cancer Cells
Mol. Endocrinol., May 1, 2003; 17(5): 804 - 817.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Abdelrahim, I. Samudio, R. Smith III, R. Burghardt, and S. Safe
Small Inhibitory RNA Duplexes for Sp1 mRNA Block Basal and Estrogen-induced Gene Expression and Cell Cycle Progression in MCF-7 Breast Cancer Cells
J. Biol. Chem., August 2, 2002; 277(32): 28815 - 28822.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. R. Ediger, S.-E. Park, and B. S. Katzenellenbogen
Estrogen Receptor Inducibility of the Human Na+/H+ Exchanger Regulatory Factor/Ezrin-Radixin-Moesin Binding Protein 50 (NHE-RF/EBP50) Gene Involving Multiple Half-Estrogen Response Elements
Mol. Endocrinol., August 1, 2002; 16(8): 1828 - 1839.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Castro-Rivera, I. Samudio, and S. Safe
Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer Elements
J. Biol. Chem., August 10, 2001; 276(33): 30853 - 30861.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Saville, H. Poukka, M. Wormke, O. A. Janne, J. J. Palvimo, M. Stoner, I. Samudio, and S. Safe
Cooperative Coactivation of Estrogen Receptor alpha in ZR-75 Human Breast Cancer Cells by SNURF and TATA-binding Protein
J. Biol. Chem., January 18, 2002; 277(4): 2485 - 2497.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society